Team members Thang Vo-Ta and Kaylie Mings represented Calla Lily at the FemTech Conference held at University of Oxford. Besides Thang’s presentation on the progress of our Callavid drug delivery & Lilyvid sample collection technologies, there were also more personal sharings with the wider community at an innovation showcase held in the observatory building of …

Our co-founder Dr. Lara Zibners was in New York to attend the Endometriosis Foundation of America Annual Blossom Ball. The exciting and impactful annual event included an important award to Drs Christine Metz and Peter K. Gregersen from The Feinstein Institutes Northwell Health for their ground breaking work in diagnosing endometriosis. A big congratulations to …

Welcome to Sabrina Franco who joins our team as a Product Development Engineer. As a recent graduate from Imperial College London and Boston University, she brings a passion for impactful solutions for womens health. We’re delighted to have you on-board!

As is always the case with the Women’s Health Innovation Series Summits, it was an invigorating and inspiring 2 days in Basel.  Besides making new connections with small & large change-makers advancing womens health – it was also great to catch-up with existing collaborators: Brandi Howard, from Premier Research our regulatory/clinical trial advisors. Professor Joyce …

Our Principal Scientist Andrew Lewis and Co-Founder Thang Vo-Ta recently took part in the inaugural Microbes in Women’s Health Congress in Copenhagen! They attended superb seminars/presentations, had great catch-ups and forged new & important connections in the groundbreaking microbiome space.  The unfolding science is getting undeniable: reproductive tract dysbiosis or the lack of a healthy …

At first glance, these are just a few “bog-standard” laboratory fume hoods & biosafety cabinets that one would expect in the labs of any R&D intensive medtech startup. But the story behind these key pieces of equipment and what they represent goes deeper… Firstly it’s outrageously expensive to build, let alone properly fit-out lab space. …

It was wonderful for members of our team to celebrate Tommy’s launch of their amazing new preterm birth centre. Always energising and inspiring to be in a room full of clinicians, researchers, midwives, engineers, supporters, and those with lived experience – for such an important cause.   We are excited about how impactful our Callavid device will …

Congratulations to our colleague Dr Serena de Gelidi and our collaborators at UCL School Of Pharmacy Catherine Tuleu and Scheilly Tsilova on their well received presentation at the Inclusivity in Women’s Health Tech event held at the Royal College of Physicians. We were delighted to share the results of our project “Supporting women needing vaginal progesterone: …

Firstly, we’re delighted to announce the first issuance of our patent for our “2nd generation” enhancements to our proprietary drug delivery and administration device, with multiple jurisdictions outstanding. Secondly, we’re proud to unveil the official trademarked name for our groundbreaking vaginal drug delivery device: CALLAVID®. This marks a pivotal moment as we step up our …

We’re delighted to see Calla Lily Clinical Care showcased in the latest print edition of Forbes France! This came from being recognised as one of the top startups at the MedFemTech Congress in Paris earlier this year. We’re always grateful for press coverage as it not only highlights our dedication but also elevates awareness around …